ELISA Kit for Glypican 3 (GPC3)
SEA971HU
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Glypican 3 (GPC3)
- Delivery Days Customer12
- Assay Detection Range0.156-10ng/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Glypican 3 (GPC3) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 0.062ng/mL
- Assay Test PrincipleThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Glypican 3 (GPC3). Standards or samples are then added to the appropriate microtiter ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Alyoussef A, Al-Gayyar MMH. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro. Biomed Pharmacother. 2018,103:362-372. doi: 10.1016/j.biopha.2018.04.060Read this paper
- Zhou F, Shang W, Yu X, et al. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment. Med Res Rev. 2018,38(2):741-767. doi: 10.1002/med.21455Read this paper
- Zaghloul RA, El-Shishtawy MM, El Galil KH, et al. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma. Eur J Pharmacol. 2015,746:353-62. doi: 10.1016/j.ejphar.2014.11.008Read this paper
- Abd El Gawad IA, Mossallam GI, Radwan NH, et al. Comparing prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins glypican-3, Alpha feto protein and carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients. J Egypt Natl Canc Inst. 2014,26(2):79-85. doi: 10.1016/j.jnci.2014.01.001Read this paper
- Abdelgawad IA, Mossallam GI, Radwan NH, et al. Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients? Asian Pac J Cancer Prev. 2013,14(12):7345-9.Read this paper
- Liu XF, Hu ZD, Liu XC, et al. Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: a systematic review and meta-analysis. Clin Biochem. 2014,47(3):196-200. doi: 10.1016/j.clinbiochem.2013.12.007Read this paper


